EIF

Investment Plan for Europe: EIF and TFG Lending Sign EUR 100 Million Deal to Finance over 4000 Businesses

Retrieved on: 
Wednesday, November 2, 2022

Through the guarantee program, TFG Lending, a subsidiary of TFG Finance Ltd. will be able to lend 87 million (100 million) to more than 4,000 small enterprises across Europe, North and South America.

Key Points: 
  • Through the guarantee program, TFG Lending, a subsidiary of TFG Finance Ltd. will be able to lend 87 million (100 million) to more than 4,000 small enterprises across Europe, North and South America.
  • The loans will be made possible by an EIF guarantee granted through the COSME initiative, with funding assistance from the European Commission.
  • At TFG Lending, valid businesses can submit an application for finance through the program.
  • Jorge C. Pecidodo, CFO at TFG Finance Ltd, said, "This agreement between TFG Lending and the EIF is a boon for the millions of SMEs who critically need access to finance.

AMP Announces $17.25M Series A Funding Round to Support the Growth of its Connected Energy Management System (ampOS)

Retrieved on: 
Tuesday, November 1, 2022

AMP, the world leader in energy management for e-mobility, has announced the closure of the Series A investment round of $17.25 million.

Key Points: 
  • AMP, the world leader in energy management for e-mobility, has announced the closure of the Series A investment round of $17.25 million.
  • With investors Ecosystem Integrity Fund (EIF) and Helios Climate Ventures on board, AMP will accelerate the development of its Connected Energy Management Platform in e-mobility applications.
  • Headquartered in Los Angeles, with offices in Detroit, Bengaluru, and Shanghai, AMP is a global leader in energy management solutions for e-mobility.
  • AMP continues to push mobility further from intelligent battery management platforms to robust fast-charging systems and complete cloud solutions for e-mobility.

Women make gains in Armenia’s thriving IT industry, notes AGBU

Retrieved on: 
Monday, October 17, 2022

Women are climbing the ranks in companies like Synergy Armenia, Renderforest, and Resal Soft paving the way for young women to break into the IT sector.

Key Points: 
  • Women are climbing the ranks in companies like Synergy Armenia, Renderforest, and Resal Soft paving the way for young women to break into the IT sector.
  • See how male employers are meeting the moment to help close Armenias gender gap in this issue of AGBU Magazine.
  • According to the Enterprise Incubator Foundation, today the share of women employed in Armenias IT sector is about
    40 percent.
  • In recent years, the IT sector in Armenia has begun to attract more women, who see the opportunity for professional growth and advancement.

The Physicians Foundation, Dr. Lorna Breen Heroes' Foundation and #FirstRespondersFirst Call on Health Organizations to Implement Solutions Physicians Deserve for Their Mental Health and Wellbeing

Retrieved on: 
Thursday, September 15, 2022

BOSTON, Sept. 15, 2022 /PRNewswire/ -- In recognition of National Physician Suicide Awareness Day (September 17, 2022), The Physicians Foundation, Dr. Lorna Breen Heroes' Foundation and #FirstRespondersFirst have come together to accelerate systems change so physicians' burnout does not become a mental health emergency. Through Vital Signs: The Campaign to Prevent Physician Suicide, the organizations are galvanizing others to take action on the system level so that each physician feels supported on an individual level.  

Key Points: 
  • Understandably, the past two and a half years of the COVID-19 pandemic have taken a toll on physicians' mental health.
  • However, eight in 10 physicians (80%) reported that there is stigma surrounding mental health and seeking mental health care among physicians.
  • The steps to better support physicians are not a secretphysicians have identified who and what supports their mental health and wellbeing most.
  • The Foundation has three main tactics to achieve long-term change:
    Advise the health care industry on wellbeing initiatives that provide holistic mental health supports.

Amazon Studios, Disney, Fox Corporation, NBCUniversal/Telemundo Enterprises, Paramount, and Warner Bros. Discovery Join Founding Partner THE HISTORY Channel® in Uniting to Support The Roybal Film and Television Production Magnet Fund

Retrieved on: 
Wednesday, September 14, 2022

A coalition of leading media companies, including Amazon Studios, Disney, Fox Corporation, NBCUniversal/Telemundo Enterprises, Paramount, and Warner Bros.

Key Points: 
  • A coalition of leading media companies, including Amazon Studios, Disney, Fox Corporation, NBCUniversal/Telemundo Enterprises, Paramount, and Warner Bros.
  • We are grateful to have the support of these extraordinary industry leaders to create opportunities for our students.
  • Roybal is just the beginning and we welcome all those who share in our mission to join us.
  • EIF is a Charity Navigator 4-Star Charity that meets all 20 BBB Charity Standards and carries the Candid Platinum Seal of Transparency.

Ambient Photonics Closes $17.5M in Equipment Financing to Support Opening of U.S.-based Manufacturing Facility

Retrieved on: 
Wednesday, September 7, 2022

Ambient Photonics has completed the initial financing for its state-of-the-art U.S. solar manufacturing facility.

Key Points: 
  • Ambient Photonics has completed the initial financing for its state-of-the-art U.S. solar manufacturing facility.
  • The debt financing lenders now join Amazons Climate Pledge Fund, Ecosystem Integrity Fund (EIF), Cthulhu Ventures, Tony Fadells Future Shape and I Squared Capital in support of climate-friendly U.S. manufacturing.
  • View the full release here: https://www.businesswire.com/news/home/20220907005411/en/
    Ambient Photonics completes initial financing for state-of-the-art U.S. solar manufacturing facility with $17.5 million in debt financing from Silicon Valley Bank and Trinity Capital.
  • Ambient Photonics was founded in 2019 in California to bring low-light energy harvesting technology to mass scale.

KU Leuven spin-off AstriVax raises € 30 million seed capital to build vaccine platform

Retrieved on: 
Thursday, August 25, 2022

Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked to Belgium-based university KU Leuven.

Key Points: 
  • Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked to Belgium-based university KU Leuven.
  • Leuven, Belgium, 25 August 2022 Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of KU Leuven spin-offs.
  • The company will also continue to build its highly innovative, first-in-class plug-and-play vaccine platform based on the ground-breaking work of co-founders Professor Johan Neyts and Kai Dallmeier, PhD, from the KU Leuven Rega Institute.
  • From 2005 to 2021, KU Leuven invested 21.7 million in its spin-off companies, and 1.46 billion of external capital was raised.

SOLVE M.E. LAUNCHES THE FIRST NATIONWIDE PSA CAMPAIGN TO BROADEN AWARENESS OF LONG COVID

Retrieved on: 
Wednesday, August 17, 2022

LOS ANGELES, Aug. 15, 2022 /PRNewswire/ -- Solve M.E. has released the first nationwide public service announcement (PSA) campaign titled "How Long?" to broaden awareness of Long Covid and highlight the need for more research to adequately help the many patients affected by this debilitating disease, which could last a lifetime.

Key Points: 
  • has released the first nationwide public service announcement (PSA) campaign titled " How Long? "
  • has released a PSA campaign to broaden awareness of Long Covid and highlight the need for more research.
  • Over 20 million Americans are suffering from Long Covid , and Long Covid could account for 15% of the nation's unfilled jobs.
  • campaign, support our work to solve Long Covid and associated conditions, learn more about participating in research, and join our advocacy efforts.

Exchange Income Corporation Announces $100 Million Bought Deal Offering of Common Shares

Retrieved on: 
Monday, August 15, 2022

WINNIPEG, Manitoba, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Exchange Income Corporation (TSX:EIF) (“EIC” or the “Corporation”) is pleased to announce that it has entered into an agreement to sell, on a bought deal basis, 2,054,000 common shares (the “Shares”) from treasury to a syndicate of underwriters (the “Underwriters”) co-led by National Bank Financial Inc. and CIBC Capital Markets. The Shares will be offered at a price of $48.70 per Share (the “Offering Price”), for gross proceeds to the Corporation of approximately $100,029,800 (the “Offering”).

Key Points: 
  • WINNIPEG, Manitoba, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Exchange Income Corporation (TSX:EIF) (EIC or the Corporation) is pleased to announce that it has entered into an agreement to sell, on a bought deal basis, 2,054,000 common shares (the Shares) from treasury to a syndicate of underwriters (the Underwriters) co-led by National Bank Financial Inc. and CIBC Capital Markets.
  • The Shares will be offered at a price of $48.70 per Share (the Offering Price), for gross proceeds to the Corporation of approximately $100,029,800 (the Offering).
  • Earlier this year the Corporation closed on its largest acquisition to date, and we are examining multiple accretive acquisition opportunities.
  • Exchange Income Corporation is a diversified acquisition-oriented company, focused in two sectors: aerospace & aviation services and equipment, and manufacturing.

Forbion Co-leads $70 Million Financing of F2G to Advance Development and Commercialization of New Antifungal Agent Olorofim

Retrieved on: 
Thursday, August 4, 2022

Forbion manages well over EUR 2 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development.

Key Points: 
  • Forbion manages well over EUR 2 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development.
  • Forbion operates a joint venture with BGV, the manager of seed and early-stage funds, especially focused on Benelux and Germany.
  • Olorofim has received orphan drug status from the European Medicines Agency for the treatment of invasive aspergillosis and invasive scedosporiosis.
  • Olorofim has also received orphan drug status from the FDA for the treatment of coccidioidomycosis scedosporiosis, and invasive aspergillosis.